Greenville, NCNCT05714969Now EnrollingIRB Ready

Thrombotic Thrombocytopenic Purpura Clinical Trial in Greenville, NC

Access cutting-edge thrombotic thrombocytopenic purpura treatment through this clinical trial at a research site in Greenville. Study-provided care at no cost to qualified participants.

Sponsored by Takeda

Quick Self-Assessment

See if you qualify for this Greenville location

Preparing your pre-screening questions...

Expert Care in Greenville

Access thrombotic thrombocytopenic purpura specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related thrombotic thrombocytopenic purpura treatment provided free

Apply for This Greenville Location

Check if you qualify for this thrombotic thrombocytopenic purpura clinical trial in Greenville, NC

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Greenville

    Convenient for NC residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Greenville site if eligible
  4. 4Begin participation

About This Thrombotic Thrombocytopenic Purpura Study in Greenville

This is a study of TAK-755 in adults with immune-mediated thrombotic thrombocytopenic purpura (iTTP). The main aim of this study is to determine the percentage of participants with a clinical (Part 1) or platelet (Part 2) response without plasma exchange during the study. Participants who have an acute attack of iTTP will receive TAK-755 and immunosuppressive therapy during their stay at the hospital until they achieve a clinical response in Part 1 or platelet response in Part 2. Participants wi

Sponsor: Takeda

Who Can Participate

Inclusion Criteria

(Part 1 and Part 2) 1. Participant must provide a signed informed consent form. A fully recognized proxy may be used per local laws for participants unable to provide consent. 2. Participant is 18 years or older at time of screening. 3. Participant has been diagnosed with de novo or relapsed iTTP. 4. Participant must be willing to fully comply with study procedures and requirements. 5. Female participants of childbearing potential must present with a negative pregnancy test and agree to employ highly effective birth control measures for duration of study. Sexually active male participants must agree to use an effective method of contraception for the duration of the study. Key

Exclusion Criteria

(Part 1 and Part 2) 1. Participant has received more than 2 pre-study PEX prior to randomization in Part 1 or first dose of investigational product in Part 2. 2. Participant has been diagnosed with cTTP or another cause of thrombotic microangiopathy (TMA). 3. Participa

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Greenville?

Yes, this clinical trial (NCT05714969) has an active research site in Greenville, NC that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Thrombotic Thrombocytopenic Purpura Treatment Options in Greenville, NC

If you're searching for thrombotic thrombocytopenic purpura treatment options in Greenville, NC, this clinical trial (NCT05714969) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Greenville research site is actively enrolling participants for this clinical trial. You'll receive care from experienced thrombotic thrombocytopenic purpura specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all thrombotic thrombocytopenic purpura clinical trials near you to find additional studies recruiting in your area.

More Pulmonary Embolism Trials in Greenville, NC

See all pulmonary embolism clinical trials recruiting in Greenville — not just this study.

Browse Pulmonary Embolism Trials in Greenville

Ready to Join in Greenville?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Greenville, NC